Skip to content

Comparative evaluation of MTA, Biodentine and TheraCal LC in vital pulp therapy of permanent molars with symptomatic pulpitis: An In Vivo Study

Comparative Evaluation of Mineral Trioxide Aggregate, Biodentine and TheraCal LC In Vital Pulp Therapy In Management Of Permanent Molars With Symptomatic Pulpitis: An In-vivo Study - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/08/093432
Enrollment
90
Registered
2025-08-21
Start date
Unknown
Completion date
Unknown
Last updated
2025-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: - Health Condition 2: K029- Dental caries, unspecified

Interventions

Intervention1: Vital pulp Therapy agent: MTA & BIODENTINE, THERACAL LC Intervention2: Progression of Caries: Permanent Molars with Symptomatic Pulpitis will be intervened as per the status of pulp inv

Sponsors

Dr. Prashant Srivastava
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Systemically healthy patients (Category: ASA 1) aged between 18-50 years diagnosed with symptomatic or asymptomatic reversible or irreversible pulpitis on a permanent molar teeth. 2.Caries extending to inner dentin(3rd or quarter) 3.Periodontially healthy patient 4.Tooth without clinical/radiographic sign of apical periodontitis. 5.The teeth that respond positively to electric pulp test as well as to cold tests

Exclusion criteria

Exclusion criteria: 1.Teeth with crown/root fractures, acute or chronic apical abscess, compromised periodontium, and open apex will be excluded. 2.Teeth exhibiting signs and symptoms of chronic irritation such as swelling, mobility, sinus tract. 3.Radiographic evidence of pathologic root resorption, inter-radicular bone loss, calcification in canal and periapical cysts. 4.Teeth which will be observed to be non-vital on cavity preparation shall be excluded

Design outcomes

Primary

MeasureTime frame
Clinically assessment of the efficacy of Vital Pulp therapy using MTA, Biodentine and Theracal LC will be assessedTimepoint: 1 month, 3 months and 6 months

Secondary

MeasureTime frame
Determination and comparison of the degree of reparative dentine formation after receiving vital pulp therapy with diverse materials.Timepoint: Determination and comparison of the degree of reparative dentine formation after 1 month, 3 months, 6 months

Countries

India

Contacts

Public ContactDr Prashant Srivastava

HKES S.NIjalingappa Institute of Dental Sciences and Research

dr.ratnakarchoudary@gmail.com9866599960

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026